Thoracic Tumours Register

Condition(s) studied

Study summary

Observational, multicenter study in patients with lung cancer and other thoracic tumors.

The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours.

Eligibility

Primary outcome measure(s)

• Describe epidemiology characteristics of lung cancer and other thoracic tumors in Spanish people — up to 10 years
  To know the epidemiology characteristics of lung cancer and other thoracic tumors in Spain, as well as clinical and histological data, diagnosis, treatments received, and prognostic factors

Trial sites (79)

+ 39 more sites — see the full list on the official registry below.

Other trials for the same condition